Clinical Trials Browser

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Unknown Primary, Urogenital Neoplasms, Colorectal Neoplasms

NCT03417115 2026-06-05

OPAL

Recruiting

6,150 enrolled

Breast

Breast Neoplasms

NCT03762733 2026-06-05

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

Enrolling by invitation

500 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT04529044 2026-06-05

177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

Phase 2 Recruiting

10 enrolled

Breast

Breast Neoplasms

NCT05000294 2026-06-05

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Phase 1/2 Recruiting

29 enrolled

BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05035836 2026-06-05

A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)

Phase 2 Recruiting

20 enrolled

Breast

Breast Neoplasms

NCT05765851 2026-06-05

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

Phase 1 Active not recruiting

108 enrolled

Breast

Breast Neoplasms

NCT06214793 2026-06-05

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)

Phase 2 Suspended

61 enrolled

Breast

Breast Neoplasms

NCT06240195 2026-06-05

BIO-PROSA

Recruiting

60 enrolled

Breast

Breast Neoplasms

NCT06257264 2026-06-05

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Phase 1 Active not recruiting

103 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06377852 2026-06-05

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Phase 3 Recruiting

500 enrolled

Breast

Breast Neoplasms

NCT06570031 2026-06-05

ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

Phase 1 Completed

46 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT07007559 2026-06-05

ASPEN-09-03

Phase 2 Recruiting

120 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT07328516 2026-06-05

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Enrolling by invitation

64,277 enrolled

BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Breast Neoplasms, Leukemia, Melanoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT07383506 2026-06-05

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Phase 1 Recruiting

90 enrolled

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT07629206 2026-06-05

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

Phase NA Not yet recruiting

400 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT07630558 2026-06-05

Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein Expression in Patients With Operated Early Breast Cancer

Active not recruiting

1,891 enrolled

Breast

Breast Neoplasms

NCT07630935 2026-06-05

NIGHT-SCAN

Not yet recruiting

100 enrolled

Breast

Breast Neoplasms, Risk Reduction Behavior

NCT07630948 2026-06-05

riboADHERE

Phase 4 Not yet recruiting

90 enrolled

Breast

Breast Neoplasms, Medication Adherence

NCT07631026 2026-06-05

Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery

Phase NA Not yet recruiting

50 enrolled

Breast

Breast Neoplasms

NCT07631052 2026-06-05

Capecitabine in ER+/HER2-negative Breast Cancer

Phase 2 Recruiting

15 enrolled

Breast

Breast Neoplasms

NCT00609791 2026-06-04

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

Phase 2 Active not recruiting

40 enrolled 16 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02541435 2026-06-04

Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer

Recruiting

1,600 enrolled

Breast

Breast Neoplasms, Cardiovascular Diseases

NCT03011684 2026-06-04

TALES

Phase 3 Recruiting

309 enrolled

Breast

Breast Neoplasms, Infertility

NCT03632941 2026-06-04

A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer

Phase 2 Terminated

8 enrolled 13 charts

Breast

Breast Neoplasms, Neoplasms

NCT03737695 2026-06-04

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

Active not recruiting

300 enrolled

Breast

Breast Neoplasms

NCT03768492 2026-06-04

ReDCoAT

Phase 2 Active not recruiting

60 enrolled

Breast

Breast Neoplasms

NCT03975959 2026-06-04

PROMESSE

Phase NA Completed

426 enrolled

BreastCNS

Breast Neoplasms, Glioblastoma, Glioma

NCT04180579 2026-06-04

Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

Phase NA Active not recruiting

34 enrolled

Breast

Alopecia, Breast Neoplasms

NCT04457895 2026-06-04

SKYPE2

Phase NA Recruiting

108 enrolled

Breast

Breast Neoplasms

NCT05232916 2026-06-04

FLAMINGO-01

Phase 3 Recruiting

750 enrolled

Breast

Breast Neoplasms, Neoplasm, Residual

NCT05386108 2026-06-04

ELECTRA

Phase 1/2 Recruiting

73 enrolled

BreastCNS

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

NCT05660083 2026-06-04

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Phase 2 Recruiting

36 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05768139 2026-06-04

PIKALO-1

Phase 1/2 Recruiting

880 enrolled

BreastGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT05870579 2026-06-04

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Phase 1 Active not recruiting

48 enrolled

Breast

Breast Neoplasms

NCT05946668 2026-06-04

Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study

Completed

35 enrolled

Breast

Breast Neoplasms

NCT06253871 2026-06-04

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Phase 1 Recruiting

383 enrolled

BreastCNSGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms, Stomach Neoplasms

NCT06274515 2026-06-04

REMERGE

Phase 4 Recruiting

320 enrolled

Breast

Breast Neoplasms

NCT06351332 2026-06-04

ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC

Phase 1 Terminated

7 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06455657 2026-06-04

Breast Cancer Education to Prisoner Women

Phase NA Completed

40 enrolled

Breast

Breast Neoplasms

NCT06756932 2026-06-04

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

Phase 1 Recruiting

120 enrolled

Breast

Breast Neoplasms

NCT06760819 2026-06-04

panSOHO

Phase 2 Recruiting

111 enrolled

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors

NCT07067138 2026-06-04

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Phase NA Suspended

175 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms